CRISPR/Cas9 technology: applications in oocytes and early embryos | Journal of Translational Medicine

CRISPR/Cas9 technology: applications in oocytes and early embryos | Journal of Translational Medicine
  • Vassena R, et al. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells. Hum Reprod Update. 2016;22(4):411–9.

    CAS 
    PubMed 

    Google Scholar
     

  • Barrangou R, et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science. 2007;315(5819):1709–12.

    CAS 
    PubMed 

    Google Scholar
     

  • Jiang F, Doudna JA. CRISPR-Cas9 structures and mechanisms. Annu Rev Biophys. 2017;46:505–29.

    CAS 
    PubMed 

    Google Scholar
     

  • Pabo CO, Peisach E, Grant RA. Design and selection of novel Cys2His2 zinc finger proteins. Annu Rev Biochem. 2001;70:313–40.

    CAS 
    PubMed 

    Google Scholar
     

  • Bogdanove AJ, Voytas DF. TAL effectors: customizable proteins for DNA targeting. Science. 2011;333(6051):1843–6.

    CAS 
    PubMed 

    Google Scholar
     

  • Jinek M, et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337(6096):816–21.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gasiunas G, et al. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci USA. 2012;109(39):E2579-2586.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Brouns SJJ, et al. Small CRISPR RNAs guide antiviral defense in prokaryotes. Science. 2008;321(5891):960–4.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Cong L, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013;339(6121):819–23.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Komor AC, Badran AH, Liu DR. CRISPR-based technologies for the manipulation of eukaryotic genomes.

  • Read More